R Tang, Y Chang, J Song - Heart Failure Reviews, 2023 - Springer
Heart failure (HF) is one of the leading causes of global health impairment. Current drugs are still limited in their effectiveness in the treatment and reversal of HF: for example, drugs …
Aortic stenosis (AS) affects about 1.5 million people in the United States and is associated with a 5-year survival rate of 20% if untreated. In these patients, aortic valve replacement is …
Myocardial infarction (MI) is accompanied by the formation of a fibrotic scar in the left ventricle (LV) and initiates significant alterations in the architecture and constituents of the …
Heart failure occurs when the heart cannot pump adequate blood to the body, which afflicts over 60 million people worldwide. Its treatment options include physiotherapy, medication …
The field of durable mechanical circulatory support (MCS) has undergone an incredible evolution over the past few decades, resulting in significant improvements in longevity and …
EC Hord, MP Hager, CM Bolch, K Bonugli… - Cardiovascular …, 2024 - Springer
Purpose For pediatric patients, extracorporeal membrane oxygenation (ECMO) remains the predominant mechanical circulatory support (MCS) modality for heart failure (HF) although …
K Wang, S Wang, Y Miao, Y Lu, H Zheng… - … Biomaterials for Tissue …, 2023 - Springer
Heart failure caused by myocardial infarction (MI) remains a major threat to human health. After MI, a series of pathological events take place, including apoptosis of cardiac cells …
Aortic stenosis (AS) affects approximately 1.5 million people in the US and is associated with a 5-year survival rate of 20% if untreated. In these patients, aortic valve replacement is …